Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

A statewide program providing colorectal cancer screening to the uninsured of South Carolina.

Eberth JM, Thibault A, Caldwell R, Josey MJ, Qiang B, Peña E, LaFrance D, Berger FG.

Cancer. 2018 May 1;124(9):1912-1920. doi: 10.1002/cncr.31250. Epub 2018 Feb 7.

2.

Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies.

Aftimos P, Rolfo C, Rottey S, Offner F, Bron D, Maerevoet M, Soria JC, Moshir M, Dreier T, Van Rompaey L, Michot JM, Silence K, Hultberg A, Gandini D, de Haard H, Ribrag V, Peeters M, Thibault A, Leupin N, Awada A.

Clin Cancer Res. 2017 Nov 1;23(21):6411-6420. doi: 10.1158/1078-0432.CCR-17-0613. Epub 2017 Aug 1.

3.

Internet Addiction, Hikikomori Syndrome, and the Prodromal Phase of Psychosis.

Stip E, Thibault A, Beauchamp-Chatel A, Kisely S.

Front Psychiatry. 2016 Mar 3;7:6. doi: 10.3389/fpsyt.2016.00006. eCollection 2016. Review.

4.

Implementation of an Interdisciplinary, Team-Based Complex Care Support Health Care Model at an Academic Medical Center: Impact on Health Care Utilization and Quality of Life.

Ritchie C, Andersen R, Eng J, Garrigues SK, Intinarelli G, Kao H, Kawahara S, Patel K, Sapiro L, Thibault A, Tunick E, Barnes DE.

PLoS One. 2016 Feb 12;11(2):e0148096. doi: 10.1371/journal.pone.0148096. eCollection 2016.

5.
6.

Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina.

Wallace K, Brandt HM, Bearden JD, Blankenship BF, Caldwell R, Dunn J, Hegedus P, Hoffman BJ, Marsh CH, Marsh WH, Melvin CL, Seabrook ME, Sterba RE, Stinson ML, Thibault A, Berger FG, Alberg AJ.

Dig Dis Sci. 2016 Jan;61(1):265-72. doi: 10.1007/s10620-015-3862-y. Epub 2015 Sep 19.

7.

Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling.

Hultberg A, Morello V, Huyghe L, De Jonge N, Blanchetot C, Hanssens V, De Boeck G, Silence K, Festjens E, Heukers R, Roux B, Lamballe F, Ginestier C, Charafe-Jauffret E, Maina F, Brouckaert P, Saunders M, Thibault A, Dreier T, de Haard H, Michieli P.

Cancer Res. 2015 Aug 15;75(16):3373-83. doi: 10.1158/0008-5472.CAN-15-0356. Epub 2015 Jul 3.

8.

Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C.

Thibault A, Brissette S, Jutras-Aswad D.

Addict Sci Clin Pract. 2015 Feb 24;10:6. doi: 10.1186/s13722-015-0029-2. Review.

9.

Guidelines from the Canadian Association of Pathologists for establishing a telepathology service for anatomic pathology using whole-slide imaging.

Canadian Association of Pathologists Telepathology Guidelines Committee, Bernard C, Chandrakanth SA, Cornell IS, Dalton J, Evans A, Garcia BM, Godin C, Godlewski M, Jansen GH, Kabani A, Louahlia S, Manning L, Maung R, Moore L, Philley J, Slatnik J, Srigley J, Thibault A, Picard DD, Cracower H, Tetu B.

J Pathol Inform. 2014 Mar 28;5(1):15. doi: 10.4103/2153-3539.129455. eCollection 2014.

10.

ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.

Silence K, Dreier T, Moshir M, Ulrichts P, Gabriels SM, Saunders M, Wajant H, Brouckaert P, Huyghe L, Van Hauwermeiren T, Thibault A, De Haard HJ.

MAbs. 2014 Mar-Apr;6(2):523-32. doi: 10.4161/mabs.27398. Epub 2013 Dec 6.

11.

Stability of midface fracture repair using absorbable plate and screw system pilot holes drilled and pin placement at angles other than 90°.

Carron MA, Zuliani G, Pereira L, Abuhamdan M, Thibault A, Dau N, Bir C.

JAMA Facial Plast Surg. 2014 Jan-Feb;16(1):42-8. doi: 10.1001/jamafacial.2013.1404.

PMID:
24158595
12.

Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers.

Camus M, Marteau P, Pocard M, Bal Dit Sollier C, Lavergne-Slove A, Thibault A, Lecleire S, Vienne A, Coffin B, Drouet L, Dray X.

Endoscopy. 2013 Jun;45(6):451-7. doi: 10.1055/s-0032-1326483. Epub 2013 Jun 3.

PMID:
23733728
13.

In vivo effect of proton-pump inhibitors on gastric plasmin-dependent fibrinolysis: a study in a porcine model.

Thibault A, Marteau P, Drouet L, Lavergne Slove A, Bal dit Sollier C, Camus M, Dray X.

Dig Liver Dis. 2012 Dec;44(12):995-8. doi: 10.1016/j.dld.2012.06.017. Epub 2012 Aug 11.

PMID:
22890053
14.

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours.

Diaz-Padilla I, Siu LL, San Pedro-Salcedo M, Razak AR, Colevas AD, Shepherd FA, Leighl NB, Neal JW, Thibault A, Liu L, Lisano J, Gao B, Lawson EB, Wakelee HA.

Br J Cancer. 2012 Aug 7;107(4):604-11. doi: 10.1038/bjc.2012.319. Epub 2012 Jul 17.

15.

Pyogenic granuloma of the colon.

Thibault A, Lavergne-Slove A, Soyer P, Ozenne V, Marteau P, Dray X.

Endoscopy. 2012;44 Suppl 2 UCTN:E155-6. doi: 10.1055/s-0031-1291697. Epub 2012 May 23. No abstract available.

PMID:
22622718
16.

Identification of field caught Anopheles gambiae s.s. and Anopheles arabiensis by TaqMan single nucleotide polymorphism genotyping.

Walker ED, Thibault AR, Thelen AP, Bullard BA, Huang J, Odiere MR, Bayoh NM, Wilkins EE, Vulule JM.

Malar J. 2007 Feb 27;6:23.

17.

Language-induced epilepsy, acquired stuttering, and idiopathic generalized epilepsy: phenotypic study of one family.

Valenti MP, Rudolf G, Carré S, Vrielynck P, Thibault A, Szepetowski P, Hirsch E.

Epilepsia. 2006 Apr;47(4):766-72.

18.

Isolated paroxysmal arousals as focal epilepsy.

Valenti MP, Froelich S, Rudolf G, Thibault A, Chassagnon S, Arzimanoglou A, Hirsch E.

Epileptic Disord. 2006 Mar;8(1):45-52.

19.

The influence of pregnancy on arterial compliance.

Bernstein IM, Thibault A, Mongeon JA, Badger GJ.

Obstet Gynecol. 2005 Mar;105(3):621-5.

PMID:
15738034
20.

Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome.

Kurzrock R, Albitar M, Cortes JE, Estey EH, Faderl SH, Garcia-Manero G, Thomas DA, Giles FJ, Ryback ME, Thibault A, De Porre P, Kantarjian HM.

J Clin Oncol. 2004 Apr 1;22(7):1287-92.

PMID:
15051776
21.

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.

Adjei AA, Croghan GA, Erlichman C, Marks RS, Reid JM, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Bruzek LM, Atherton P, Thibault A, Palmer PA, Kaufmann SH.

Clin Cancer Res. 2003 Jul;9(7):2520-6.

22.

Developing a tracking system for coagulation factor concentrates in southern Ontario.

Walker IR, Sek JT, Almonte TM, Carruthers JB, Chan AK, Pai MK, Thibault AA, Heddle NM.

Transfusion. 2003 May;43(5):556-62.

PMID:
12702174
23.

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.

Cortes J, Albitar M, Thomas D, Giles F, Kurzrock R, Thibault A, Rackoff W, Koller C, O'Brien S, Garcia-Manero G, Talpaz M, Kantarjian H.

Blood. 2003 Mar 1;101(5):1692-7. Epub 2002 Oct 31.

PMID:
12411300
24.

Disturbances in essential fatty acid metabolism in patients receiving long-term home parenteral nutrition.

Ling PR, Ollero M, Khaodhiar L, McCowen K, Keane-Ellison M, Thibault A, Tawa N, Bistrian BR.

Dig Dis Sci. 2002 Aug;47(8):1679-85.

PMID:
12184517
25.

Iron deficiency anemia in patients receiving home total parenteral nutrition.

Khaodhiar L, Keane-Ellison M, Tawa NE, Thibault A, Burke PA, Bistrian BR.

JPEN J Parenter Enteral Nutr. 2002 Mar-Apr;26(2):114-9.

PMID:
11871735
26.

Inflammatory mediators in patients receiving long-term home parenteral nutrition.

Ling PR, Khaodhiar L, Bistrian BR, Keane-Ellison M, Thibault A, Tawa N.

Dig Dis Sci. 2001 Nov;46(11):2484-9.

PMID:
11713958
27.

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

Karp JE, Lancet JE, Kaufmann SH, End DW, Wright JJ, Bol K, Horak I, Tidwell ML, Liesveld J, Kottke TJ, Ange D, Buddharaju L, Gojo I, Highsmith WE, Belly RT, Hohl RJ, Rybak ME, Thibault A, Rosenblatt J.

Blood. 2001 Jun 1;97(11):3361-9.

PMID:
11369625
28.

Cholecystokinin (CCK) secretion in patients with severe short bowel syndrome (SSBS).

Ling PR, Sheikh M, Boyce P, Keane-Ellison M, Thibault A, Burke P, Freedman S, Bistrian BR.

Dig Dis Sci. 2001 Apr;46(4):859-64.

PMID:
11330425
29.
30.

Upper airway collapsibility and cephalometric variables in patients with obstructive sleep apnea.

Sforza E, Bacon W, Weiss T, Thibault A, Petiau C, Krieger J.

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):347-52.

PMID:
10673170
31.

Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition.

Chan S, McCowen KC, Bistrian BR, Thibault A, Keane-Ellison M, Forse RA, Babineau T, Burke P.

Surgery. 1999 Jul;126(1):28-34.

PMID:
10418589
32.

Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells.

Bar-Ner M, Thibault A, Tsokos M, Magrath IT, Samid D.

Clin Cancer Res. 1999 Jun;5(6):1509-16.

33.

[Starling resister and stability of sleep ventilation].

Krieger J, Petiau C, Sforza E, Weiss T, Thibault A, Bazin A.

Neurophysiol Clin. 1998 Dec;28(6):493-506. Review. French.

PMID:
9894229
34.

Pharyngeal critical pressure in patients with obstructive sleep apnea syndrome. Clinical implications.

Sforza E, Petiau C, Weiss T, Thibault A, Krieger J.

Am J Respir Crit Care Med. 1999 Jan;159(1):149-57.

PMID:
9872833
35.

A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer.

Thibault A, Figg WD, Bergan RC, Lush RM, Myers CE, Tompkins A, Reed E, Samid D.

Tumori. 1998 Jan-Feb;84(1):87-9.

PMID:
9619724
36.

Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate.

Miller AC, Whittaker T, Thibault A, Samid D.

Int J Radiat Biol. 1997 Aug;72(2):211-8.

PMID:
9269314
37.

Meeting summary: Workshop conference on endocrine therapy of advanced prostate cancer, airlie house, November 3-4, 1996.

Santen RJ, Thibault A, Myers C, Chung L.

Urol Oncol. 1997 Jan-Feb;3(1):31-8.

PMID:
21227050
38.

The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cells.

Walls R, Thibault A, Liu L, Wood C, Kozlowski JM, Figg WD, Sampson ML, Elin RJ, Samid D.

Prostate. 1996 Sep;29(3):177-82.

PMID:
8827086
39.

Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.

Shack S, Miller A, Liu L, Prasanna P, Thibault A, Samid D.

Clin Cancer Res. 1996 May;2(5):865-72.

40.

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE.

Clin Cancer Res. 1996 Mar;2(3):483-91.

41.
42.

Influence of phototherapy treatment duration for seasonal affective disorder: outcome at one vs. two weeks.

Labbate LA, Lafer B, Thibault A, Rosenbaum JF, Sachs GS.

Biol Psychiatry. 1995 Dec 1;38(11):747-50.

PMID:
8580228
43.

Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables.

Dawson NA, Cooper MR, Figg WD, Headlee DJ, Thibault A, Bergan RC, Steinberg SM, Sausville EA, Myers CE, Sartor O.

Cancer. 1995 Aug 1;76(3):453-62.

PMID:
8625127
44.

Phase I study of phenylacetate administered twice daily to patients with cancer.

Thibault A, Samid D, Cooper MR, Figg WD, Tompkins AC, Patronas N, Headlee DJ, Kohler DR, Venzon DJ, Myers CE.

Cancer. 1995 Jun 15;75(12):2932-8.

PMID:
7773944
45.

A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer.

Figg WD, Thibault A, Cooper MR, Reid R, Headlee D, Dawson N, Kohler DR, Reed E, Sartor O.

Cancer. 1995 Apr 15;75(8):2159-64.

PMID:
7535186
46.

Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine.

Piscitelli SC, Thibault A, Figg WD, Tompkins A, Headlee D, Lieberman R, Samid D, Myers CE.

J Clin Pharmacol. 1995 Apr;35(4):368-73.

PMID:
7650225
47.

Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer.

Figg WD, Sartor O, Cooper MR, Thibault A, Bergan RC, Dawson N, Reed E, Myers CE.

Am J Med. 1995 Apr;98(4):412-4. No abstract available.

PMID:
7535978
48.

Acute renal toxicity associated with suramin in the treatment of prostate cancer.

Figg WD, Cooper MR, Thibault A, Headlee D, Humphrey J, Bergan RC, Reed E, Sartor O.

Cancer. 1994 Sep 1;74(5):1612-4.

PMID:
8062193
49.

A double-blind trial of bupropion versus desipramine for bipolar depression.

Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF.

J Clin Psychiatry. 1994 Sep;55(9):391-3.

PMID:
7929019
50.

Evaluation of cutaneous and proprioceptive sensation in children: a reliability study.

Thibault A, Forget R, Lambert J.

Dev Med Child Neurol. 1994 Sep;36(9):796-812.

PMID:
7926330

Supplemental Content

Loading ...
Support Center